These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7329940)

  • 61. [Informations to the problem of smoking and health (author's transl)].
    Z Erkr Atmungsorgane; 1978 Feb; 152(2):206-9. PubMed ID: 685317
    [No Abstract]   [Full Text] [Related]  

  • 62. Do the emotional side-effects of hormonal contraceptives come from pharmacologic or psychological mechanisms?
    Robinson SA; Dowell M; Pedulla D; McCauley L
    Med Hypotheses; 2004; 63(2):268-73. PubMed ID: 15236788
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Hepatic lesions by oral contraceptives (author's transl].
    Lopez M
    Pathologica; 1979; 71(1012):253-8. PubMed ID: 471546
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Recommendations of the swiss family planning association regarding the indications for oral contraceptives (author's transl)].
    Schweiz Rundsch Med Prax; 1979 Oct; 68(41):1330-2. PubMed ID: 530936
    [No Abstract]   [Full Text] [Related]  

  • 65. Study of rigevidon for oral contraception in a family planning clinic in Kota Bahru, Kelantan.
    Ang Eng Suan ; Karim HA
    Malays J Reprod Health; 1990 Jun; 8(1):31-7. PubMed ID: 12316342
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Could contraceptives with progestational effect cause voice changes?].
    Ned Tijdschr Geneeskd; 1975 Nov; 119(44):1726-7. PubMed ID: 1214879
    [No Abstract]   [Full Text] [Related]  

  • 67. [On the influence of hormonal contraception on the secretion of tears (author's transl)].
    Wild H; Benad A
    Fol Ophthalmol; 1978; 3(1):53-6. PubMed ID: 12261660
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Breast cancer and use of antihypertensive drugs and oral contraceptives: results of a case-control study (author's transl)].
    Clavel F; Lê M; Laplanche A
    Bull Cancer; 1981; 68(5):449-55. PubMed ID: 7332791
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Antithrombin and heparin-neutralizing activity in sera of women using and not using hormonal contraceptives].
    Stepanauskas M; Weissbach-Rieger A; Schwarzenecker K; Hansche N; Egger E; Heine H
    Z Med Lab Diagn; 1979; 20(5):295-301. PubMed ID: 549319
    [No Abstract]   [Full Text] [Related]  

  • 70. [New aspects of contraception in adolescents].
    Rey-Stocker I
    Rev Med Suisse Romande; 1975 Sep; 95(9):693-9. PubMed ID: 1215721
    [No Abstract]   [Full Text] [Related]  

  • 71. [Evaluation of various liver function and blood coagulation tests in early stages of treatment with oral contraceptives].
    Del Vecchio-Blanco C; Rinaldi M; Saffiotti O; Moro CO; Albanese R; De Maria C
    Clin Ter; 1978 Nov; 87(3):233-42. PubMed ID: 753573
    [No Abstract]   [Full Text] [Related]  

  • 72. [Evaluation of a contraceptive without estrogens (Exlutona) (author's transl)].
    Iliev G; Iliev D
    Med Klin; 1974 Sep; 69(38):1537-40. PubMed ID: 4437440
    [No Abstract]   [Full Text] [Related]  

  • 73. [Anovulation syndrome in nulligravidae following intake of hormonal contraceptives (author's transl)].
    Müller R; Alexander H; Glück S; Herter U
    Zentralbl Gynakol; 1980; 102(1):33-41. PubMed ID: 7467923
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Immunological dtermination of at. III (author's transl)].
    Brogioni M; Biancalani L; Albertazzi M
    Quad Sclavo Diagn; 1976 Sep; 12(3):288-94. PubMed ID: 1025592
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Ocular side effects through oral contraceptives (author's transl)].
    Rochels R; Nover A
    Geburtshilfe Frauenheilkd; 1980 Aug; 40(8):713-5. PubMed ID: 7409430
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [What is new in hormonal contraception? (Author's transl)].
    Emperaire JC
    Contracept Fertil Sex (Paris); 1980; 8(7):575-82. PubMed ID: 12336497
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The 20 mcg ethinylestradiol and 150 mcg desogestrel pill: six month, multicenter study in 235 women].
    Serfaty D
    Fertil Contracept Sex; 1990 Jun; 18(6):407-12. PubMed ID: 12283254
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The clinico-pharmacological characteristics of hormonal contraceptives for enteral use].
    Korkhov VV
    Farmakol Toksikol; 1990; 53(1):77-80. PubMed ID: 2328809
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Contraception. Method, efficacy, choice, contra-indications, monitoring, risk].
    Mensier A; Lopes P
    Rev Prat; 1996 Jan; 46(1):119-28. PubMed ID: 8596885
    [No Abstract]   [Full Text] [Related]  

  • 80. What women want and what their doctors need--how do women evaluate the quality of contraceptive methods and products introduced by their gynaecologist? A different perspective.
    van de Weijer P
    Eur J Contracept Reprod Health Care; 2005; 10 Suppl 1():2-6. PubMed ID: 16356875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.